Lataa...
A comparative pharmacokinetic study of DRL_BZ, a candidate biosimilar of bevacizumab, with Avastin(®) (EU and US) in healthy male subjects
AIM: The aim of this study was to compare the pharmacokinetics (PK) of DRL_BZ with that of EU‐approved (reference medicinal product; RMP) and US‐licensed (reference product; RP) bevacizumab (Avastin(®)) in healthy male subjects. METHODS: In this double‐blind, parallel‐group, Phase 1 study (BZ‐01‐001...
Tallennettuna:
| Julkaisussa: | Br J Clin Pharmacol |
|---|---|
| Päätekijät: | , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
John Wiley and Sons Inc.
2018
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6138499/ https://ncbi.nlm.nih.gov/pubmed/29943831 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.13691 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|